International Technology Transactions

Our team is fluent in the languages of science, business, and the law. We are able to successfully translate between those fields into actionable business strategies that impacts your bottom line. Our individual practitioners have successfully advised our clients through the maze of legal and commercial issues that arise in connection with the acquisition, development, adoption, and commercialization of new technologies and IP assets in a wide range of cutting-edge industries in the United States, Europe, and Asia.

Specifically, we are experts with drafting, negotiating and advising our clients with respect to:

Our team structures and negotiates agreements and provides sophisticated business advice on the legal and commercial issues that arise in complex multijurisdictional technology and IP-related transactions, including mergers and acquisitions, patent and software procurement, patent licensing and valuation, and development, collaboration, joint-venture, and distribution deals. Such deals include:

Business Deals:

On behalf of a Berkeley-based synthetic biology company, we advised on the closing of a complex international license agreement having a component in-licensed from a prominent university; all patent applications related to the deal are drafted and prosecuted by our attorneys.
On behalf of a California artificial intelligence-powered Avatar app developer, we advised on the legal de-risking of the platform by drafting comprehensive Privacy Policies, Terms of Service, and other legal documents that take a novel approach to copyright, copyleft, public domain, rights of publicity, and other legal doctrines.
On behalf of a Carlsbad, San Diego-based biotechnology company, we advised on the creation of a joint venture with a multi-billion dollar publicly traded European biotech, and conducted all related due diligence.
On behalf of a major international specialty chemical manufacturer and distributor, we drafted legal opinions to block assertions of patent infringement, either direct or contributory, under theories of patent validity/invalidity, non-patent exclusivities, data exclusivities, and other legal theories.

On behalf of a leading generic drug manufacturer, we led a team of IP, corporate, and tax attorneys in nine-figure acquisition of pharmaceutical manufacturer for Fortune 500® company.
On behalf of a major US Active Pharmaceutical Ingrediant (API) manufacturer, we created a legal strategy for the company to avoid significant liabilities under the license of the API manufacturing process.
On behalf of a Fortune 500® ANDA applicant, we provided pharmaceutical product clearance and successfully condluded due diligence.
We have created numerous entities for clients including limited liability companies (LLCs) in a variety of states including California, Delaware, Wyoming, Arizona and Nevada; Delaware corporations; California corporations including C-corps., S-corps., and partnerships; and non-profit corporations including 501(c)(3) and 501(c)(5) corporations.
On behalf of numerous clients, we have drafted and negotiated international technology license agreements with counterparts in China, Japan, Korea, Taiwan, Europe, Canada, Mexico, and Brazil, among other nations and jurisdictions.
We have helped countless company founders with identifying and obtaining private and non-dilutive government funding for biotech, pharmaceutical, and medical device startups, including SBIR, STTR, and TABA funding.

For information on these and other legal, regulatory, and business matters, please contact us.

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

San Diego Technology Transactions Law Firm - Orange County Business Agreement Counsel - Los Angeles Technology Transaction Counsel - International Business Contract Formation - Complex IP Transactions - Technology Transaction Due Diligence Attorneys